[DISCLOSURE]
ST Pharm (237690) reported on April 21 that its operating profit in the first quarter soared 105.6 percent to 17.81 billion won (US$15.72 million) from the same period last year.
Its revenue hiked 54.8 percent to 47.82 billion won and net profit 39.0 percent to 13.45 billion won on-year.
By Hwang You-mee (
theinvestor@heraldcorp.com)